Abstract

BackgroundSince image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods. A promising approach is to identify and characterize circulating tumor cells (CTC) in the peripheral blood of HNSCC patients. In this pilot study, we assessed which non-hematopoietic cell types are identifiable and whether their numbers differ in pre- and postoperative blood samples.Methods20 ml citrated peripheral blood was taken from 10 HNSCC patients before and after curative resection. CTC were enriched using density gradient centrifugation. CTC presence was verified by multi-immunofluorescence staining against cytokeratin (CK; epithelial), N-cadherin (mesenchymal); CD133 (stem-cell), CD45 (hematopoietic) and DAPI (nucleus). Individual cell type profiles were analyzed.ResultsWe were able to detect cells with epithelial properties like CK+/N-cadherin−/CD45− and CK+/CD133−/CD45− as well as cells with mesenchymal features such as N-cadherin+/CK−/CD45− and cells with both characteristics like N-cadherin+/CK+/CD45−. We also observed cells showing stem cell-like features like CD133+/CK−/CD45− and cells with both epithelial and stem cell-like features such as CD133+/CK+/CD45−. The number of CK positive cells (p = 0.002), N-cadherin positive cells (p = 0.002) and CD133 positive cells (p = 0.01) decreased significantly after resection. Kaplan-Meier test showed that the survival was significantly shorter when N-cadherin+ cells were present after resection (p = 0.04; 474 vs. 235 days; [HR] = 3.1).ConclusionsThis is - to the best of our knowledge- the first pilot study identifying different CTC populations in peripheral blood of HNSCC patients and showing that these individual cell type profiles may have distinct clinical implications.

Highlights

  • Since image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods to characterize entities and to find markers that could help choosing the appropriate treatment and monitoring response at an early stage.Circulating tumor cells (CTC) could serve as a ‘‘liquid biopsy’’ for individualizing and monitoring therapy in patients with solid tumors [1, 2]

  • We recently developed a CTC detection method based on multi-parameter immunofluorescence microscopy (MPIM) that includes but is not solely dependent on epithelial markers such as CK or epithelial cell adhesion molecule (EpCAM) and detects cells with mesenchymal and stem cell-like characteristics [17]

  • We detected cells that stained positive for CD133 which is believed to be a cancer stem cell marker and found subtypes such as CD133+/CK2/CD452 and CD133+/CK+/CD452 cells

Read more

Summary

Introduction

Since image based diagnostic tools fail to detect early metastasis in HNSCC it is crucial to develop minimal invasive diagnostic methods to characterize entities and to find markers that could help choosing the appropriate treatment and monitoring response at an early stage.Circulating tumor cells (CTC) could serve as a ‘‘liquid biopsy’’ for individualizing and monitoring therapy in patients with solid tumors [1, 2]. Since image based diagnostic tools fail to detect early metastasis in HNSCC it is crucial to develop minimal invasive diagnostic methods to characterize entities and to find markers that could help choosing the appropriate treatment and monitoring response at an early stage. Since image based diagnostic tools fail to detect early metastasis in head and neck squamous cell carcinoma (HNSCC) it is crucial to develop minimal invasive diagnostic methods. A promising approach is to identify and characterize circulating tumor cells (CTC) in the peripheral blood of HNSCC patients. In this pilot study, we assessed which non-hematopoietic cell types are identifiable and whether their numbers differ in pre- and postoperative blood samples. Kaplan-Meier test showed that the survival was significantly shorter when N-cadherin+ cells were present after resection (p50.04; 474 vs. 235 days; [HR]53.1)

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.